Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125739042 | 12573904 | 2 | F | 201206 | 20160730 | 20160720 | 20160808 | EXP | US-AMGEN-USASP2016091492 | AMGEN | 69.00 | YR | E | M | Y | 0.00000 | 20160808 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125739042 | 12573904 | 1 | PS | XGEVA | DENOSUMAB | 1 | Unknown | U | 125320 | UNKNOWN FORMULATION | |||||||||
| 125739042 | 12573904 | 2 | SS | XTANDI | ENZALUTAMIDE | 1 | Oral | 160 MG, QD | 51520 | MG | 1507023PC | 0 | 160 | MG | QD | ||||
| 125739042 | 12573904 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 125739042 | 12573904 | 4 | SS | LUPRON | LEUPROLIDE ACETATE | 1 | Unknown | 0 | |||||||||||
| 125739042 | 12573904 | 5 | C | ZETIA | EZETIMIBE | 1 | 0 | ||||||||||||
| 125739042 | 12573904 | 6 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 125739042 | 12573904 | 7 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
| 125739042 | 12573904 | 8 | C | FENOFIBRATE. | FENOFIBRATE | 1 | 0 | ||||||||||||
| 125739042 | 12573904 | 9 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
| 125739042 | 12573904 | 10 | C | ASPIRIN 81 | ASPIRIN | 1 | 0 | ||||||||||||
| 125739042 | 12573904 | 11 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 125739042 | 12573904 | 12 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
| 125739042 | 12573904 | 13 | C | ZYTIGA | ABIRATERONE ACETATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125739042 | 12573904 | 1 | Product used for unknown indication |
| 125739042 | 12573904 | 2 | Prostate cancer |
| 125739042 | 12573904 | 3 | Blood cholesterol increased |
| 125739042 | 12573904 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125739042 | 12573904 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125739042 | 12573904 | Adverse event | |
| 125739042 | 12573904 | Bone pain | |
| 125739042 | 12573904 | Bursitis | |
| 125739042 | 12573904 | Decreased appetite | |
| 125739042 | 12573904 | Fatigue | |
| 125739042 | 12573904 | Gait disturbance | |
| 125739042 | 12573904 | Hot flush | |
| 125739042 | 12573904 | Insomnia | |
| 125739042 | 12573904 | Liver disorder | |
| 125739042 | 12573904 | Malignant neoplasm progression | |
| 125739042 | 12573904 | Middle insomnia | |
| 125739042 | 12573904 | Nasopharyngitis | |
| 125739042 | 12573904 | Nausea | |
| 125739042 | 12573904 | Norovirus test positive | |
| 125739042 | 12573904 | Prostatic specific antigen increased | |
| 125739042 | 12573904 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125739042 | 12573904 | 2 | 20150122 | 20160620 | 0 | |
| 125739042 | 12573904 | 3 | 2016 | 0 | ||
| 125739042 | 12573904 | 13 | 20160713 | 0 |